+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

E

Actively Recruiting

Healthy Volunteer

Researchers are studying the effectiveness, safety, and tolerability of a vaccine against Clostridioides difficile C. difficile infection in adults aged 65 years and older. The study aims to reduce the number of C. difficile infections, a serious cause of diarrhea, by comparing the vaccine to a placebo. This is a phase 3, randomized, double-blinded trial sponsored by Pfizer. Participants will receive either the C. difficile vaccine or a saline placebo, both given as shots into the upper arm muscle. The study duration varies based on the occurrence of diarrhea events related to C. difficile infection, lasting up to about three and a half years. The study may end earlier if sufficient data is collected or if the vaccine is found ineffective. Vaccination involves two doses, and participants will be closely monitored during and after vaccination. During the study, participants will have three planned clinic visits and three phone visits, followed by annual clinic visits until the study ends. If participants have three or more loose stools in 24 hours, they must save the next stool and contact the study site for infection assessment, which can occur in person or remotely. Researchers will track local and systemic reactions, adverse events, and the incidence of C. difficile infections as primary outcomes over the study period.

Age: 65Years +All GendersPhase 3
185 locations
S

Actively Recruiting

Researchers are studying the unique natural history of blood sugar control, insulin sensitivity, and beta-cell function in obese adolescents at risk for developing type 2 diabetes. This observational study aims to understand how these factors and their causes change as youth transition through puberty, providing important information that could help design future treatments and prevention strategies for youth-onset type 2 diabetes. The study will carefully examine a large group of young people at risk for type 2 diabetes using detailed biochemical, clinical, and psychosocial assessments. Participants aged 8 to 15 years who meet specific criteria related to obesity, puberty stage, and blood sugar levels will be observed over an average of 2.5 years. No treatments or medications are being tested instead, the study focuses on tracking natural changes and risk factors over time. Throughout the study, participants will undergo regular evaluations to monitor blood sugar control, beta-cell function, insulin sensitivity, and fatty acid metabolism. These measures will be collected along with clinical and psychosocial data to better understand the progression toward type 2 diabetes. The research team will review these outcomes continuously during the study period, aiming to improve knowledge about diabetes risk in youth and inform future care approaches.

Age: 8Years - 15YearsAll Genders
20 locations
E

Actively Recruiting

Researchers are investigating mental and behavioral health challenges among American Indian and Alaska Native communities, where access to culturally appropriate behavioral health services is limited. The study evaluates the effectiveness of Family Spirit Strengths FSS, a secondary prevention program designed to improve mental health by building coping skills, self-efficacy, and community and cultural connections. This research is conducted through a randomized controlled trial comparing FSS to an evidence-based nutrition education program. Participants are randomly assigned to one of two groups. Those in the FSS group receive 4 to 16 typically 6 to 8 intervention visits tailored to individual mental and behavioral health needs, guided by in-session surveys. The comparison group receives six bi-weekly lessons over up to four months from the Family Spirit Nurture nutrition education curriculum, which promotes healthy early childhood growth and feeding practices. Throughout the study, participants undergo assessments measuring mental health outcomes, including the number of poor mental health days, depressive and anxiety symptoms, and substance use behaviors. These evaluations occur at baseline and follow-up points up to 9 months. The study also monitors alcohol and drug involvement through validated screening tools. Participation continues until study completion in 2028, with ongoing data collection to understand the programs impacts on mental and behavioral health.

Age: 14Years +FEMALEPhase Not Applicable
3 locations